PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NOVN.SW vs. ROG.SW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NOVN.SWROG.SW
YTD Return12.42%12.07%
1Y Return12.83%14.36%
3Y Return (Ann)12.92%-7.51%
5Y Return (Ann)6.03%0.94%
10Y Return (Ann)6.18%2.57%
Sharpe Ratio0.770.77
Sortino Ratio1.141.15
Omega Ratio1.151.15
Calmar Ratio1.220.35
Martin Ratio3.402.54
Ulcer Index3.75%5.80%
Daily Std Dev16.56%19.28%
Max Drawdown-42.25%-58.88%
Current Drawdown-10.47%-29.05%

Fundamentals


NOVN.SWROG.SW
Market CapCHF 184.65BCHF 211.40B
EPSCHF 5.02CHF 13.25
PE Ratio18.4019.81
PEG Ratio3.171.14
Total Revenue (TTM)CHF 49.94BCHF 58.79B
Gross Profit (TTM)CHF 37.42BCHF 42.64B
EBITDA (TTM)CHF 19.71BCHF 15.92B

Correlation

-0.50.00.51.00.6

The correlation between NOVN.SW and ROG.SW is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

NOVN.SW vs. ROG.SW - Performance Comparison

The year-to-date returns for both stocks are quite close, with NOVN.SW having a 12.42% return and ROG.SW slightly lower at 12.07%. Over the past 10 years, NOVN.SW has outperformed ROG.SW with an annualized return of 6.18%, while ROG.SW has yielded a comparatively lower 2.57% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
0.35%
17.76%
NOVN.SW
ROG.SW

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NOVN.SW vs. ROG.SW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and Roche Holding AG (ROG.SW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NOVN.SW
Sharpe ratio
The chart of Sharpe ratio for NOVN.SW, currently valued at 0.87, compared to the broader market-4.00-2.000.002.004.000.87
Sortino ratio
The chart of Sortino ratio for NOVN.SW, currently valued at 1.24, compared to the broader market-4.00-2.000.002.004.006.001.24
Omega ratio
The chart of Omega ratio for NOVN.SW, currently valued at 1.16, compared to the broader market0.501.001.502.001.16
Calmar ratio
The chart of Calmar ratio for NOVN.SW, currently valued at 1.06, compared to the broader market0.002.004.006.001.06
Martin ratio
The chart of Martin ratio for NOVN.SW, currently valued at 3.01, compared to the broader market0.0010.0020.0030.003.01
ROG.SW
Sharpe ratio
The chart of Sharpe ratio for ROG.SW, currently valued at 0.83, compared to the broader market-4.00-2.000.002.004.000.83
Sortino ratio
The chart of Sortino ratio for ROG.SW, currently valued at 1.23, compared to the broader market-4.00-2.000.002.004.006.001.23
Omega ratio
The chart of Omega ratio for ROG.SW, currently valued at 1.16, compared to the broader market0.501.001.502.001.16
Calmar ratio
The chart of Calmar ratio for ROG.SW, currently valued at 0.41, compared to the broader market0.002.004.006.000.41
Martin ratio
The chart of Martin ratio for ROG.SW, currently valued at 2.01, compared to the broader market0.0010.0020.0030.002.01

NOVN.SW vs. ROG.SW - Sharpe Ratio Comparison

The current NOVN.SW Sharpe Ratio is 0.77, which is comparable to the ROG.SW Sharpe Ratio of 0.77. The chart below compares the historical Sharpe Ratios of NOVN.SW and ROG.SW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
0.87
0.83
NOVN.SW
ROG.SW

Dividends

NOVN.SW vs. ROG.SW - Dividend Comparison

NOVN.SW's dividend yield for the trailing twelve months is around 3.59%, less than ROG.SW's 3.65% yield.


TTM20232022202120202019201820172016201520142013
NOVN.SW
Novartis AG
3.59%3.77%3.91%3.94%3.72%3.27%3.98%3.98%4.35%3.58%3.17%3.86%
ROG.SW
Roche Holding AG
3.65%3.89%3.20%2.40%2.91%2.77%3.41%3.33%3.48%2.89%2.89%2.95%

Drawdowns

NOVN.SW vs. ROG.SW - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.25%, smaller than the maximum ROG.SW drawdown of -58.88%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and ROG.SW. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-13.94%
-25.44%
NOVN.SW
ROG.SW

Volatility

NOVN.SW vs. ROG.SW - Volatility Comparison

Novartis AG (NOVN.SW) and Roche Holding AG (ROG.SW) have volatilities of 5.51% and 5.40%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%JuneJulyAugustSeptemberOctoberNovember
5.51%
5.40%
NOVN.SW
ROG.SW

Financials

NOVN.SW vs. ROG.SW - Financials Comparison

This section allows you to compare key financial metrics between Novartis AG and Roche Holding AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in CHF except per share items